Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlternative Liq Regulatory News (ALF)

Share Price Information for Alternative Liq (ALF)

Share Price is delayed by 15 minutes
Get Live Data
0.0215    0.00 (0.00%)
Bid:
0.003
Ask:
0.04
Spread: 0.037 (1,233.333%)
Market Cap: $3.14m
ALF Live PriceLast checked at - London Stock Exchange

Intraday Alternative Liq Share Chart

Portfolio Update

3 Jul 2025 09:45

RNS Number : 6117P
Alternative Liquidity Fund Limited
03 July 2025
 

ALTERNATIVE LIQUIDITY FUND LIMITED

Registered in Guernsey - Number 60552

LEI NUMBER 213800R5CHD76J3LU713

 

Registered Office:

1 Royal Plaza, Royal Avenue,

St Peter Port, Guernsey, GY1 2HL

 

3 July 2025

PORTFOLIO UPDATE

The Board and the Investment Adviser have received a positive update from Vision Brazil with regard to the FCVS RJ Fund. As previously communicated in the 2024 interim accounts and recent fact sheets, Vision and their advisers have been negotiating the FCVS RJ credits through the government system and have achieved some success. Over 80% of the credits in the portfolio which were approved by Caixa and officially handed over to the Treasury have now been novated. Having signed a novation contract with the Treasury, the related cash and bonds have been deposited into the V3 FIDC securities account.

A further tranche remains under review by the Treasury, and this may transition through to novation in the next several months.

With respect to the first novated tranche, Vision will now work with tax lawyers, service providers and the independent directors to determine and execute the following:

- the fiscal deductions that need to be settled in Brazil;

- the distribution waterfall approval;

- directors' resolution approval;

- execution of FIDC amortization;

- execution of FX transaction;

- transfer of funds among intermediate offshore vehicles; and

- sending notice of redemption to the Cayman administrator (Suntera); and

- Finally the joint authorization from Vision and Suntera for payment on behalf of each investor.

Vision estimates that the above steps will take approximately one month to complete. With respect to the waterfall of payments, we expect the V Invest RJ Loan to be settled in full first (ALF's share being circa US$2.67mlm), followed by the repayment of the recent US$3mln recapitalisation loan. The balance will then be distributed to all shareholders.

ALF owns 21.5% of the Vision RJ Fund and using an approximate estimate for the expected deductions that are listed above, we anticipate that ALF should receive a figure roughly equivalent to Vision's March 31, NAV for the RJ Fund. This was US$14.88mln.

We would like to re-iterate that this recovery estimate is an indicative guideline only. At this point we do not have accurate data with respect to the deductions listed above. Consequently, the recovery number could increase or decrease.

Based on the estimated timeline received from Vision, it is possible that this exercise could be completed prior to the end of August, however, accurate timing is difficult to ascertain at this point.

Once funds have been received, the Board will determine the appropriate amount of cash to be distributed through redeemable B shares. The Board will also take soundings from shareholders with a view to making recommendations with respect to the remaining assets in the portfolio.

Enquiries

 

Tim Gardner, Hindsight Solutions Limited

Tel. +44 7917 630 460

Email: timgardner@hindsightsolutions.co.uk

Website:   https://alternativeliquidityfund.com/

 

 

Apex Fund and Corporate Services (Guernsey) Limited

Telephone: +44 (0) 20 3530 3111

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUFIFVTDEIVIIE
Date   Source Headline
11th Mar 20222:05 pmRNSSecond Price Monitoring Extn
11th Mar 20222:00 pmRNSPrice Monitoring Extension
11th Mar 202211:05 amRNSSecond Price Monitoring Extn
11th Mar 202211:00 amRNSPrice Monitoring Extension
11th Mar 20229:05 amRNSSecond Price Monitoring Extn
11th Mar 20229:00 amRNSPrice Monitoring Extension
2nd Mar 20224:41 pmRNSSecond Price Monitoring Extn
2nd Mar 20224:37 pmRNSPrice Monitoring Extension
2nd Mar 20222:05 pmRNSSecond Price Monitoring Extn
2nd Mar 20222:00 pmRNSPrice Monitoring Extension
2nd Mar 202211:05 amRNSSecond Price Monitoring Extn
2nd Mar 202211:00 amRNSPrice Monitoring Extension
28th Feb 20222:34 pmRNSResult of Meeting
23rd Feb 20225:00 pmRNSNet Asset Value and Factsheet 31 December 21
9th Feb 20228:22 amRNSShareholder Circular and Notice of GM
4th Feb 20222:01 pmRNSPrice Monitoring Extension
4th Feb 202211:05 amRNSSecond Price Monitoring Extn
4th Feb 202211:00 amRNSPrice Monitoring Extension
8th Dec 20214:02 pmRNSResult of AGM
8th Dec 20213:56 pmRNSChange of name of Administrator and Secretary
1st Dec 20215:00 pmRNSNet Asset Value and Fact Sheet 30 September 21
29th Oct 20217:00 amRNSReturn of Capital
26th Oct 20214:30 pmRNSAnnual Financial Report and Notice of AGM
7th Oct 20212:05 pmRNSSecond Price Monitoring Extn
7th Oct 20212:00 pmRNSPrice Monitoring Extension
21st Sep 20215:00 pmRNSNet Asset Value and Fact Sheet 30 June 21
8th Sep 202111:05 amRNSSecond Price Monitoring Extn
8th Sep 202111:00 amRNSPrice Monitoring Extension
8th Sep 20219:05 amRNSSecond Price Monitoring Extn
8th Sep 20219:00 amRNSPrice Monitoring Extension
7th Sep 20214:41 pmRNSSecond Price Monitoring Extn
7th Sep 20214:36 pmRNSPrice Monitoring Extension
7th Sep 20212:05 pmRNSSecond Price Monitoring Extn
7th Sep 20212:00 pmRNSPrice Monitoring Extension
7th Sep 202111:06 amRNSSecond Price Monitoring Extn
7th Sep 202111:00 amRNSPrice Monitoring Extension
20th Aug 20218:00 amRNSCircular & Notice of GM
26th Jul 20219:05 amRNSSecond Price Monitoring Extn
26th Jul 20219:00 amRNSPrice Monitoring Extension
16th Jul 202112:06 pmRNSAgreement
10th Jun 20214:41 pmRNSSecond Price Monitoring Extn
10th Jun 20214:35 pmRNSPrice Monitoring Extension
28th May 20219:00 amRNSNet Asset Value and Fact Sheet 31 March 21
25th Mar 20219:31 amRNSReturn of Capital
24th Mar 20214:20 pmRNSHalf-year Report
5th Mar 20214:02 pmRNSNet Asset Value and Fact Sheet 31 December 20
26th Jan 202111:01 amRNSTransfer to the Specialist Fund Segment
25th Jan 20218:00 amRNSRemoval- Alternative Liquidity Fund Limited
15th Jan 20214:41 pmRNSSecond Price Monitoring Extn
15th Jan 20214:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.